Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - TACTI-002 data presented at SITC for Efti in 1st line NSCLC (ASX:IMM)

SYDNEY, AUSTRALIA – 11 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing no...read more

Immutep Webcast to discuss clinical data presented at SITC (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep - New Patents Granted in Japan and South Korea for Efti (ASX:IMM)

SYDNEY, AUSTRALIA – 9 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

Immutep - Abstract for Efti selected for SITC 2022 Press Conference (ASX:IMM)

SYDNEY, AUSTRALIA – 04 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing nov...read more

Immutep - Late Breaking Abstract accepted for SITC Oral Presentation (ASX:IMM)

SYDNEY, AUSTRALIA – 03 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

Immutep Corporate Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep to Participate in Two Upcoming Investor Conferences (ASX:IMM)

SYDNEY, AUSTRALIA – 02 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

Immutep - Annual Report filed on Form 20-F with SEC (ASX:IMM)

To view the annual report, download the attached PDF.

Immutep - Independent DMC recommends to continue TACTI-003 as planned (ASX:IMM)

SYDNEY, AUSTRALIA – 26 October 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing...read more

Immutep - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:IMM)

To view the report, download the attached PDF.

Immutep - Notice of Annual General Meeting/Proxy Form (ASX:IMM)

TAKE NOTICE that the 2022 Annual General Meeting of shareholders of Immutep Limited (ACN 009 237 889) will be held at the time and date specified below... For more information, download the attac...read more

Immutep - Appendix 4G and Corporate Governance Statement (ASX:IMM)

To view the appendix, download the attached PDF.

Immutep - Annual Report to shareholders (ASX:IMM)

Dear Fellow Shareholder: I’m delighted to present Immutep’s annual report for the financial year 2022. Immutep continued to forge its leadership role in the emerging LAG-3 landsc...read more

Immutep - Change in substantial holding (ASX:IMM)

For more information, download the attached PDF.

Immutep - Application for quotation of securities (ASX:IMM)

For more information, download the attached PDF.

Viewing: 136 - 150 of 200 Previous | Next